Japanese drugmaker Astellas will soon extend its limits on 340B pricing to hospitals for its medication to treat overreactive bladder, [...] …
Category: Pharma Industry
Drugmakers Amgen and Johnson & Johnson have announced they will provide refunds to 340B providers on past purchases of multiple [...] …
Eighty-five percent of DSH hospitals earned more in estimated 340B revenue in 2022 than they incurred in charity care costs, [...] …
After a federal appeals court upheld Arkansas’ 340B contract pharmacy access law, a major drug manufacturer has asked a federal [...] …
A federal judge recently dismissed a large California health system’s whistleblower case against four pharmaceutical companies for alleged fraudulent 340B [...] …
Two More Drugmakers End 340B Contract Pharmacy Restrictions in Arkansas After Appeals Court Decision
Drugmakers EMD Serono and Sanofi will lift 340B contract pharmacy restrictions in Arkansas after a federal appeals court upheld a [...] …
Months after nine drug manufacturers restored 340B contract pharmacy access in Arkansas, two more companies have announced they will exempt [...] …
The 340B program may increase medication costs for self-insured employers, a recent study from a pharmaceutical industry outsourcing and analytics [...] …
News Alert
Mississippi House Passes 340B Contract Pharmacy Bill, Two Days After Senate Passes Similar Bill
The Mississippi state house yesterday passed a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific pharmacy benefit [...] …
Exclusive
Imminent Enforcement of Arkansas 340B Contract Pharmacy Law to Follow Court Decision Upholding It
After a federal appeals court recently upheld Arkansas’ 340B contract pharmacy law, the state will initiate enforcement against 14 drugmakers [...] …